What to expect when you take Omnaris and have Confusion?

Do you take Omnaris and have Confusion? Find out below what new side effects and undetected conditions people who are 50-59 years old may have. This prediction is created after we perform predictive analysis on health care big data. It will be updated regularly.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and monitor them (see testimonials).



On Oct, 16, 2018

743 reports have been studied.


Females aged 50 to 59 :

570 related reports were analyzed:

Most common symptoms:

Asthma
  • 20.7% for females aged 50 (±5) who take Omnaris
Bronchitis
  • 6.14% for females aged 50 (±5) who take Omnaris
Chest pain
  • 10.88% for females aged 50 (±5) who take Omnaris
Cough
  • 12.98% for females aged 50 (±5) who take Omnaris
Diarrhea
  • 6.14% for females aged 50 (±5) who take Omnaris
Dizziness
  • 13.86% for females aged 50 (±5) who take Omnaris
Dyspnea
  • 21.75% for females aged 50 (±5) who take Omnaris
Fall
  • 8.07% for females aged 50 (±5) who take Omnaris
Fatigue
  • 18.6% for females aged 50 (±5) who take Omnaris
Headache
  • 18.6% for females aged 50 (±5) who take Omnaris
Heart rate increased
  • 6.32% for females aged 50 (±5) who take Omnaris
High blood pressure
  • 16.14% for females aged 50 (±5) who take Omnaris
Hypersensitivity
  • 5.79% for females aged 50 (±5) who take Omnaris
Hypotension
  • 5.26% for females aged 50 (±5) who take Omnaris
Malaise
  • 11.23% for females aged 50 (±5) who take Omnaris
Nasal congestion
  • 6.14% for females aged 50 (±5) who take Omnaris
Nasopharyngitis
  • 12.46% for females aged 50 (±5) who take Omnaris
Nausea
  • 8.6% for females aged 50 (±5) who take Omnaris
Oropharyngeal pain
  • 6.32% for females aged 50 (±5) who take Omnaris
Pain
  • 6.32% for females aged 50 (±5) who take Omnaris
Paraesthesia
  • 7.02% for females aged 50 (±5) who take Omnaris
Pneumonia
  • 7.19% for females aged 50 (±5) who take Omnaris
Rashes
  • 5.79% for females aged 50 (±5) who take Omnaris
Sinusitis
  • 5.26% for females aged 50 (±5) who take Omnaris
Stress and anxiety
  • 8.07% for females aged 50 (±5) who take Omnaris
The flu
  • 8.07% for females aged 50 (±5) who take Omnaris
Weakness
  • 9.65% for females aged 50 (±5) who take Omnaris
Weight decreased
  • 5.09% for females aged 50 (±5) who take Omnaris
Weight increased
  • 5.09% for females aged 50 (±5) who take Omnaris
Wheezing
  • 8.42% for females aged 50 (±5) who take Omnaris

Most common co-existing conditions:

Asthma
  • 47.37% for females aged 50 (±5) who take Omnaris
High blood pressure
  • 8.95% for females aged 50 (±5) who take Omnaris
Hypersensitivity
  • 5.61% for females aged 50 (±5) who take Omnaris
Rheumatoid arthritis
  • 8.42% for females aged 50 (±5) who take Omnaris
Rhinitis perennial
  • 5.61% for females aged 50 (±5) who take Omnaris
back to top

Males aged 50 to 59 :

173 related reports were analyzed:

Most common symptoms:

Arthritis
  • 6.36% for males aged 50 (±5) who take Omnaris
Asthma
  • 19.08% for males aged 50 (±5) who take Omnaris
Body temperature decreased
  • 7.51% for males aged 50 (±5) who take Omnaris
Bronchitis
  • 5.78% for males aged 50 (±5) who take Omnaris
Chest pain
  • 8.09% for males aged 50 (±5) who take Omnaris
Chronic obstructive pulmonary disease
  • 6.36% for males aged 50 (±5) who take Omnaris
Cough
  • 14.45% for males aged 50 (±5) who take Omnaris
Dizziness
  • 10.4% for males aged 50 (±5) who take Omnaris
Drug ineffective
  • 5.2% for males aged 50 (±5) who take Omnaris
Dyspnea
  • 18.5% for males aged 50 (±5) who take Omnaris
Fatigue
  • 22.54% for males aged 50 (±5) who take Omnaris
Fever
  • 9.83% for males aged 50 (±5) who take Omnaris
Headache
  • 10.4% for males aged 50 (±5) who take Omnaris
Heart rate increased
  • 10.4% for males aged 50 (±5) who take Omnaris
High blood pressure
  • 14.45% for males aged 50 (±5) who take Omnaris
Hypersensitivity
  • 8.67% for males aged 50 (±5) who take Omnaris
Hypotension
  • 6.94% for males aged 50 (±5) who take Omnaris
Joint pain
  • 5.2% for males aged 50 (±5) who take Omnaris
Lower respiratory tract infection
  • 5.2% for males aged 50 (±5) who take Omnaris
Malaise
  • 19.08% for males aged 50 (±5) who take Omnaris
Muscle aches
  • 5.78% for males aged 50 (±5) who take Omnaris
Muscle spasms
  • 6.94% for males aged 50 (±5) who take Omnaris
Nasopharyngitis
  • 21.97% for males aged 50 (±5) who take Omnaris
Nausea
  • 8.09% for males aged 50 (±5) who take Omnaris
Oropharyngeal pain
  • 8.09% for males aged 50 (±5) who take Omnaris
Pain
  • 12.14% for males aged 50 (±5) who take Omnaris
Pneumonia
  • 11.56% for males aged 50 (±5) who take Omnaris
Productive cough
  • 10.4% for males aged 50 (±5) who take Omnaris
Rashes
  • 5.78% for males aged 50 (±5) who take Omnaris
Respiratory disorder
  • 5.78% for males aged 50 (±5) who take Omnaris
Sinus congestion
  • 6.94% for males aged 50 (±5) who take Omnaris
Sinusitis
  • 5.2% for males aged 50 (±5) who take Omnaris
Sputum discolored
  • 6.36% for males aged 50 (±5) who take Omnaris
The flu
  • 14.45% for males aged 50 (±5) who take Omnaris
Weakness
  • 13.29% for males aged 50 (±5) who take Omnaris
Weight increased
  • 6.36% for males aged 50 (±5) who take Omnaris
Wheezing
  • 15.03% for males aged 50 (±5) who take Omnaris

Most common co-existing conditions:

Asthma
  • 54.34% for males aged 50 (±5) who take Omnaris
back to top

Do you take Omnaris and have Confusion:

  • To personalize this prediction to you, including to your gender, age, personal and family history, and more: Click here

Related studies

omnaris

Omnaris has active ingredients of ciclesonide. It is often used in allergies. (latest outcomes from Omnaris 1,232 users)

confusion

Confusion has been reported by people with depression, high blood pressure, pain, multiple sclerosis, stress and anxiety (latest reports from 49,437 Confusion patients).

General study

Recent updates

Recent general studies
Recent personal studies

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on ePatient.care is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the ePatient.care site and its content is at your own risk.